Unresectable Neuroendocrine Carcinoma

1 clinical trials · Condition

Record	Firm	Date
Testing the Addition of an Anti-cancer Drug, BAY 1895344, to Usual Chemotherapy for Advanced Stage Solid Tumors, With a Specific Focus on Patients With Small Cell Lung Cancer, Poorly Differentiated Neuroendocrine Cancer, and Pancreatic Cancer (NCT04514497)	National Cancer Institute (NCI)	2021-10-20

Every clearance here is in the API, with alerts when new ones post.